日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Women with first recurrence of endometrial cancer: who are they? An analysis of real-world data of the JAGO/NOGGO

首次复发子宫内膜癌的女性:她们是谁?JAGO/NOGGO真实世界数据分析

Proppe, Louisa; Zimmermann, Julia Sarah Maria; Hachenberg, Jens; Pan, Teresa; Tsibulak, Irina; Radosa, Julia Caroline; Botscharnikow, Christine; Flethe, Chiara; Sehouli, Jalid; Pietzner, Klaus

Consensus on surgical technique for sentinel lymph node dissection in cervical cancer

宫颈癌前哨淋巴结清扫术手术技术共识

Bizzarri, Nicolò; Obermair, Andreas; Hsu, Heng-Cheng; Chacon, Enrique; Collins, Anna; Tsibulak, Irina; Mutombo, Alex; Abu-Rustum, Nadeem R; Balaya, Vincent; Buda, Alessandro; Cibula, David; Covens, Allan; Fanfani, Francesco; Ferron, Gwenaël; Frumovitz, Michael; Guani, Benedetta; Kocian, Roman; Kohler, Christhardt; Leblanc, Eric; Lecuru, Fabrice; Leitao, Mario M Jr; Mathevet, Patrice; Mueller, Michael D; Papadia, Andrea; Pareja, Rene; Plante, Marie; Querleu, Denis; Scambia, Giovanni; Tanner, Edward; Zapardiel, Ignacio; Garcia, Jaime R; Ramirez, Pedro T

BRCA loss of function including BRCA1 DNA-methylation, but not BRCA-unrelated homologous recombination deficiency, is associated with platinum hypersensitivity in high-grade ovarian cancer

BRCA功能丧失(包括BRCA1 DNA甲基化)而非与BRCA无关的同源重组缺陷,与高级别卵巢癌的铂类药物超敏反应相关。

Fiegl, Heidelinde; Schnaiter, Simon; Reimer, Daniel U; Leitner, Katharina; Nardelli, Petra; Tsibulak, Irina; Wieser, Verena; Wimmer, Katharina; Schamschula, Esther; Marth, Christian; Zeimet, Alain G

INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line

INOVATYON/ENGOT-ov5 研究:一项随机 III 期国际研究,比较曲贝替定/聚乙二醇化脂质体阿霉素 (PLD) 序贯铂类化疗与卡铂/PLD 方案治疗复发性卵巢癌(末次铂类化疗后 6-12 个月内进展)患者的疗效。

Colombo, N; Gadducci, A; Sehouli, J; Rulli, E; Mäenpää, J; Sessa, C; Montes, A; Ottevanger, N B; Berger, R; Vergote, I; D'Incalci, M; Churruca Galaz, C; Chekerov, R; Nyvang, G B; Riniker, S; Herbertson, R; Fossati, R; Barretina-Ginesta, M P; Deryal, M; Mirza, M R; Biagioli, E; Iglesias, M; Funari, G; Romeo, M; Tasca, G; Pardo, B; Tognon, G; Rubio-Pérez, M J; DeCensi, A; De Giorgi, U; Zola, P; Benedetti Panici, P; Aglietta, M; Arcangeli, V; Zamagni, C; Bologna, A; Westermann, A; Heinzelmann-Schwarz, V; Tsibulak, I; Wimberger, P; Poveda, A

Combined chemotherapy and pembrolizumab salvages multi-chemotherapy agent and avelumab resistant choriocarcinoma: A case report

联合化疗和帕博利珠单抗挽救多药化疗和阿维鲁单抗耐药的绒毛膜癌:病例报告

Lehmann, M; Hosa, H; Bartl, T; Tsibulak, I; Polterauer, S; Pötsch, N; Seckl, M J; Marth, C

Dubious effects of methadone as an "anticancer" drug on ovarian cancer cell-lines and patient-derived tumor-spheroids

美沙酮作为“抗癌”药物对卵巢癌细胞系和患者来源的肿瘤球体的影响令人生疑

Heidelinde Fiegl, Judith Hagenbuchner, Christiana Kyvelidou, Beata Seeber, Sieghart Sopper, Irina Tsibulak, Verena Wieser, Elisabeth Reiser, Julia Roessler, Kaisa Huhtinen, Olli Carpén, Walther Parson, Susanne Sprung, Christian Marth, Michael J Ausserlechner, Alain G Zeimet

The impact of COVID-19 pandemic on the rate of newly diagnosed gynecological and breast cancers: a tertiary center perspective

新冠疫情对新发妇科和乳腺癌病例发生率的影响:一家三级医疗中心的视角

Knoll, Katharina; Reiser, Elisabeth; Leitner, Katharina; Kögl, Johanna; Ebner, Christoph; Marth, Christian; Tsibulak, Irina

Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective

新冠疫情期间妇科癌症诊断数量下降:奥地利视角

Tsibulak, Irina; Reiser, Elisabeth; Bogner, Gerhard; Petru, Edgar; Hell-Teutsch, Johanna; Reinthaller, Alexander; Weirather, Cornelia; Weiss, Tatjana; Bozsa, Szabolcs; Puschacher, Barbara; Hall, Mirijam; Hittler, Doris; Hrauda, Katharina; Thell, Elisabeth; Clauss, Sabine; Pozniak, Johanna; Alicke, Sebastian; Gangl, Daniela; Gamperl, Gottfried; Ebner, Christoph; Knoll, Katharina; Leitner, Katharina; Schilcher, Andrea; Schinnerl, Marina; Sigl, Verena; Singer, Christian; Aigmüller, Thomas; Hofstätter, Birgit; Marth, Christian

The miR-34 family and its clinical significance in ovarian cancer

miR-34家族及其在卵巢癌中的临床意义

Welponer, Hannah; Tsibulak, Irina; Wieser, Verena; Degasper, Christine; Shivalingaiah, Giridhar; Wenzel, Sören; Sprung, Susanne; Marth, Christian; Hackl, Hubert; Fiegl, Heidelinde; Zeimet, Alain G

Tumor necrosis factor receptor modulator spermatogenesis-associated protein 2 is a novel predictor of outcome in ovarian cancer

肿瘤坏死因子受体调节剂精子发生相关蛋白 2 是卵巢癌预后的新预测因子

Verena Wieser, Irina Tsibulak, Christine Degasper, Hannah Welponer, Katharina Leitner, Walther Parson, Alain G Zeimet, Christian Marth, Heidelinde Fiegl